S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:CRSP

CRISPR Therapeutics SEC Filings & 10K Form

$199.88
-10.16 (-4.84 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$199.01
Now: $199.88
$220.20
50-Day Range
$121.55
MA: $158.70
$210.04
52-Week Range
$32.30
Now: $199.88
$220.20
Volume4.00 million shs
Average Volume2.41 million shs
Market Capitalization$14.23 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.37

SEC Filings

CRISPR Therapeutics (NASDAQ:CRSP) SEC Filings

DateFilerForm TypeView
01/15/2021
3:12 PM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2021
3:10 PM
CRISPR Therapeutics (Filer)
Form 424B5
01/04/2021
3:12 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
3:02 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
6:12 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
6:14 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4/A
12/17/2020
8:06 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2020
6:11 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
7:16 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2020
7:12 AM
CRISPR Therapeutics (Filer)
Form 424B5
12/10/2020
3:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:54 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
6:50 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2020
3:32 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:26 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
8:14 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2020
4:30 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:08 AM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2020
7:03 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2020
7:58 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
3:44 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
12:51 PM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G
10/06/2020
4:48 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:45 PM
CRISPR Therapeutics (Issuer)
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:38 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:34 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:32 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
5:09 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2020
7:10 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
4:05 PM
CRISPR Therapeutics (Subject)
Versant Venture Capital IV, L.P. (Filed by)
Form SC 13D/A
09/18/2020
3:30 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
7:00 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
8:49 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
10:04 AM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G
09/10/2020
1:54 PM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G
09/03/2020
8:21 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:46 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:44 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:42 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
3:11 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
3:20 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2020
3:46 PM
CRISPR Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/27/2020
3:41 PM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/27/2020
3:35 PM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
4:26 PM
CRISPR Therapeutics (Subject)
GLAXOSMITHKLINE PLC (Filed by)
Form SC 13D/A
07/09/2020
3:00 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:14 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:12 PM
CRISPR Therapeutics (Filer)
Form 424B5
06/29/2020
3:24 PM
CRISPR Therapeutics (Filer)
Form 424B5
06/26/2020
3:33 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2020
3:28 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
6:02 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:58 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:49 PM
Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:45 PM
CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:42 PM
CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/15/2020
3:37 PM
CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:33 PM
CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:31 PM
CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
5:04 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2020
4:32 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
3:34 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
3:32 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:37 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
8:11 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
3:38 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
8:12 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
3:50 PM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2020
10:01 AM
CRISPR Therapeutics (Filer)
Form D/A
04/09/2020
3:42 PM
CRISPR Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/12/2020
3:20 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:20 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:20 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:10 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:13 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
3:13 PM
CRISPR Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2020
2:19 PM
CRISPR Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
02/12/2020
5:02 AM
CRISPR Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G
01/29/2020
3:16 PM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
3:09 PM
Bayer Global Investments B.V. (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13D/A
01/10/2020
3:49 PM
Bayer Global Investments B.V. (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13D/A
12/27/2019
3:06 PM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
6:01 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
3:05 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:05 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:05 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
4:12 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
6:53 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:12 PM
CRISPR Therapeutics (Filer)
Form 424B5
11/21/2019
3:09 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:07 PM
CAGNONI PABLO J (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:27 PM
CRISPR Therapeutics (Filer)
Form 424B5
11/19/2019
7:21 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
3:30 PM
CAGNONI PABLO J (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
5:35 PM
CAGNONI PABLO J (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
5:34 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
7:01 AM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2019
6:05 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.